Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Feb;114(4):832–836. doi: 10.1111/j.1476-5381.1995.tb13279.x

The inhibition of CYP enzymes in mouse and human liver by pilocarpine.

T Kimonen 1, R O Juvonen 1, E Alhava 1, M Pasanen 1
PMCID: PMC1510190  PMID: 7773543

Abstract

1. Pilocarpine is a cholinomimetic natural alkaloid. Its interactions with testosterone hydroxylations, coumarin 7-hydroxylase (COH), dimethylnitrosamine N-demethylase (DMNA), pentoxyresorufin O-dealkylase (PROD) and 7-ethoxyresorufin O-deethylase (EROD), which are indicative of the activities of cytochrome P4502A5 (CYP2A5) or 6, 2E1, 2B, 1A, were examined in mouse and human liver microsomes. 2. In mouse liver microsomes the IC50 values of pilocarpine were 6 microM for COH and testosterone 15 alpha-hydroxylase (T15 alpha OH) activities, 4 microM for PROD, approximately 100 microM for DMNA and testosterone 6 beta-hydroxylase (T6 beta OH) activities and > 1 mM for EROD activity. 3. In human liver microsomes, the IC50 value for COH was 6 microM and for DMNA 10 microM; T15 alpha OH and PROD activities were not detectable but T6 beta OH and testosterone 16 beta/2 beta-hydroxylase activities were moderately inhibited (IC50 70 microM). 4. These results suggest that pilocarpine has (i) a high affinity towards phenobarbitone-inducible CYP2A4/5 and CYP2B activities in mouse liver, (ii) a high affinity towards CYP2A6 in human liver microsomes and (iii) a moderate affinity towards CYP3A enzyme(s) in both microsomal preparations. 5. The low IC50 concentrations in vitro indicate potential metabolic interactions between pilocarpine and several P450 enzymes.

Full text

PDF
832

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitio A. A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem. 1978 Apr;85(2):488–491. doi: 10.1016/0003-2697(78)90245-2. [DOI] [PubMed] [Google Scholar]
  2. Anderson R. A., Cowle J. B. Influence of pH on the effect of pilocarpine on aqueous dynamics. Br J Ophthalmol. 1968 Aug;52(8):607–611. doi: 10.1136/bjo.52.8.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bornheim L. M., Correia M. A. Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol. Mol Pharmacol. 1990 Sep;38(3):319–326. [PubMed] [Google Scholar]
  4. Burke M. D., Thompson S., Elcombe C. R., Halpert J., Haaparanta T., Mayer R. T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol. 1985 Sep 15;34(18):3337–3345. doi: 10.1016/0006-2952(85)90355-7. [DOI] [PubMed] [Google Scholar]
  5. Camus A. M., Geneste O., Honkakoski P., Béréziat J. C., Henderson C. J., Wolf C. R., Bartsch H., Lang M. A. High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Mol Carcinog. 1993;7(4):268–275. doi: 10.1002/mc.2940070410. [DOI] [PubMed] [Google Scholar]
  6. Crespi C. L., Penman B. W., Leakey J. A., Arlotto M. P., Stark A., Parkinson A., Turner T., Steimel D. T., Rudo K., Davies R. L. Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis. 1990 Aug;11(8):1293–1300. doi: 10.1093/carcin/11.8.1293. [DOI] [PubMed] [Google Scholar]
  7. Ellis P. P., Littlejohn K., Deitrich R. A. Enzymatic hydrolysis of pilocarpine. Invest Ophthalmol. 1972 Sep;11(9):747–751. [PubMed] [Google Scholar]
  8. Gonzalez F. J. The molecular biology of cytochrome P450s. Pharmacol Rev. 1988 Dec;40(4):243–288. [PubMed] [Google Scholar]
  9. Guengerich F. P. Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicol Lett. 1994 Feb 1;70(2):133–138. doi: 10.1016/0378-4274(94)90156-2. [DOI] [PubMed] [Google Scholar]
  10. Guengerich F. P., Müller-Enoch D., Blair I. A. Oxidation of quinidine by human liver cytochrome P-450. Mol Pharmacol. 1986 Sep;30(3):287–295. [PubMed] [Google Scholar]
  11. Guengerich F. P., Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol. 1991 Jul-Aug;4(4):391–407. doi: 10.1021/tx00022a001. [DOI] [PubMed] [Google Scholar]
  12. Honkakoski P., Lang M. A. Mouse liver phenobarbital-inducible P450 system: purification, characterization, and differential inducibility of four cytochrome P450 isozymes from D2 mouse. Arch Biochem Biophys. 1989 Aug 15;273(1):42–57. doi: 10.1016/0003-9861(89)90160-4. [DOI] [PubMed] [Google Scholar]
  13. Iwasaki M., Lindberg R. L., Juvonen R. O., Negishi M. Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction. Biochem J. 1993 Apr 15;291(Pt 2):569–573. doi: 10.1042/bj2910569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Juvonen R. O., Kaipainen P. K., Lang M. A. Selective induction of coumarin 7-hydroxylase by pyrazole in D2 mice. Eur J Biochem. 1985 Oct 1;152(1):3–8. doi: 10.1111/j.1432-1033.1985.tb09156.x. [DOI] [PubMed] [Google Scholar]
  15. Kinirons M. T., O'Shea D., Downing T. E., Fitzwilliam A. T., Joellenbeck L., Groopman J. D., Wilkinson G. R., Wood A. J. Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men. Clin Pharmacol Ther. 1993 Dec;54(6):621–629. doi: 10.1038/clpt.1993.199. [DOI] [PubMed] [Google Scholar]
  16. Kitada M., Kamataki T., Itahashi K., Rikihisa T., Kanakubo Y. Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations. Biochem Pharmacol. 1987 Feb 15;36(4):453–456. doi: 10.1016/0006-2952(87)90350-9. [DOI] [PubMed] [Google Scholar]
  17. Lindberg R., Burkhart B., Ichikawa T., Negishi M. The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene. J Biol Chem. 1989 Apr 15;264(11):6465–6471. [PubMed] [Google Scholar]
  18. Miles J. S., McLaren A. W., Forrester L. M., Glancey M. J., Lang M. A., Wolf C. R. Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem J. 1990 Apr 15;267(2):365–371. doi: 10.1042/bj2670365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Murray M. P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet. 1992 Aug;23(2):132–146. doi: 10.2165/00003088-199223020-00005. [DOI] [PubMed] [Google Scholar]
  20. Mäenpä J., Juvonen R., Raunio H., Rautio A., Pelkonen O. Metabolic interactions of methoxsalen and coumarin in humans and mice. Biochem Pharmacol. 1994 Oct 7;48(7):1363–1369. doi: 10.1016/0006-2952(94)90558-4. [DOI] [PubMed] [Google Scholar]
  21. Mäenpä J., Pelkonen O., Cresteil T., Rane A. The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. J Steroid Biochem Mol Biol. 1993 Jan;44(1):61–67. doi: 10.1016/0960-0760(93)90152-m. [DOI] [PubMed] [Google Scholar]
  22. Mäenpä J., Sigusch H., Raunio H., Syngelmä T., Vuorela P., Vuorela H., Pelkonen O. Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem Pharmacol. 1993 Mar 9;45(5):1035–1042. doi: 10.1016/0006-2952(93)90247-t. [DOI] [PubMed] [Google Scholar]
  23. Mäenpä J., Syngelmä T., Honkakoski P., Lang M. A., Pelkonen O. Comparative studies on coumarin and testosterone metabolism in mouse and human livers. Differential inhibitions by the anti-P450Coh antibody and metyrapone. Biochem Pharmacol. 1991 Aug 22;42(6):1229–1235. doi: 10.1016/0006-2952(91)90258-7. [DOI] [PubMed] [Google Scholar]
  24. NASH T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J. 1953 Oct;55(3):416–421. doi: 10.1042/bj0550416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Negishi M., Lindberg R., Burkhart B., Ichikawa T., Honkakoski P., Lang M. Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase. Biochemistry. 1989 May 16;28(10):4169–4172. doi: 10.1021/bi00436a007. [DOI] [PubMed] [Google Scholar]
  26. Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsalus I. C., Gotoh O. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993 Jan-Feb;12(1):1–51. doi: 10.1089/dna.1993.12.1. [DOI] [PubMed] [Google Scholar]
  27. OMURA T., SATO R. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964 Jul;239:2370–2378. [PubMed] [Google Scholar]
  28. Otton S. V., Brinn R. U., Gram L. F. In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver. Drug Metab Dispos. 1988 Jan-Feb;16(1):15–17. [PubMed] [Google Scholar]
  29. Pasanen M., Pelkonen O. The expression and environmental regulation of P450 enzymes in human placenta. Crit Rev Toxicol. 1994;24(3):211–229. doi: 10.3109/10408449409021606. [DOI] [PubMed] [Google Scholar]
  30. Patton T. F., Francoeur M. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs. Am J Ophthalmol. 1978 Feb;85(2):225–229. doi: 10.1016/s0002-9394(14)75953-7. [DOI] [PubMed] [Google Scholar]
  31. Pelkonen O., Sotaniemi E. A., Ahokas J. T. Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons. Br J Clin Pharmacol. 1985 Jan;19(1):59–66. doi: 10.1111/j.1365-2125.1985.tb02613.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Raunio H., Syngelmä T., Pasanen M., Juvonen R., Honkakoski P., Kairaluoma M. A., Sotaniemi E., Lang M. A., Pelkonen O. Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochem Pharmacol. 1988 Oct 15;37(20):3889–3895. doi: 10.1016/0006-2952(88)90070-6. [DOI] [PubMed] [Google Scholar]
  33. Schuetz J. D., Kauma S., Guzelian P. S. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J Clin Invest. 1993 Aug;92(2):1018–1024. doi: 10.1172/JCI116607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  35. Tsujimoto A., Doi T., Kojima S. Potent inhibitory action of pilocarpine on hepatic drug metabolism. Jpn J Pharmacol. 1972 Oct;22(5):736–739. doi: 10.1254/jjp.22.736. [DOI] [PubMed] [Google Scholar]
  36. Verhoeven G., Dierickx P., de Moor P. Stimulation effect of neurotransmitters on the aromatization of testosterone by Sertoli cell-enriched cultures. Mol Cell Endocrinol. 1979 Mar;13(3):241–253. doi: 10.1016/0303-7207(79)90084-4. [DOI] [PubMed] [Google Scholar]
  37. Wahlström G. Some aspects of the changes induced by chronic barbital treatments in the male rat. Drug Alcohol Depend. 1979 May-Jul;4(3-4):221–233. doi: 10.1016/0376-8716(79)90002-4. [DOI] [PubMed] [Google Scholar]
  38. Waxman D. J., Ko A., Walsh C. Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J Biol Chem. 1983 Oct 10;258(19):11937–11947. [PubMed] [Google Scholar]
  39. Wrighton S. A., Stevens J. C. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol. 1992;22(1):1–21. doi: 10.3109/10408449209145319. [DOI] [PubMed] [Google Scholar]
  40. Wrighton S. A., Vandenbranden M., Stevens J. C., Shipley L. A., Ring B. J., Rettie A. E., Cashman J. R. In vitro methods for assessing human hepatic drug metabolism: their use in drug development. Drug Metab Rev. 1993;25(4):453–484. doi: 10.3109/03602539308993982. [DOI] [PubMed] [Google Scholar]
  41. Yamano S., Tatsuno J., Gonzalez F. J. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry. 1990 Feb 6;29(5):1322–1329. doi: 10.1021/bi00457a031. [DOI] [PubMed] [Google Scholar]
  42. Yun C. H., Shimada T., Guengerich F. P. Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene. Cancer Res. 1992 Apr 1;52(7):1868–1874. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES